25.39MMarket Cap-10837P/E (TTM)
2.270High2.190Low2.96KVolume2.250Open2.210Pre Close6.56KTurnover0.08%Turnover RatioLossP/E (Static)11.54MShares5.50052wk High3.36P/B7.80MFloat Cap1.20052wk Low--Dividend TTM3.55MShs Float9.250Historical High--Div YieldTTM3.62%Amplitude1.200Historical Low2.216Avg Price1Lot Size
CytoMed Therapeutics Stock Forum
Update on Clinical Milestone - CytoMed Therapeutics Announces First Patient Dosed in its First-in-Human Phase I Clinical Trial of Allogeneic CAR-Gamma Delta T Cell Therapy in Patients with Advanced Solid Tumours or Haematological Malignancies
SINGAPORE, Nov. 20, 2024 (GLOBE NEWSWIRE) -- Further to an announcement on October 7, 2024, CytoMed Therapeutics Limited(NASDAQ:GDTC) ("CytoMed" or "Company"), a Singapore-based biopharmaceutical company focused on harnes...
CytoMed Therapeutics' first-in-human Phase I ANGELICA clinical trial using its patented donor allogeneic chimeric antigen receptor T cell (CAR-T cell) against blood and solid tumors received co-funding support from the NMRC Clinical Trial Grant
SINGAPORE, Oct. 07, 2024 (GLOBE NEWSWIRE) -- CytoMed Therapeutics Limited (NASDAQ:GDTC) ("CytoMed" or the "Company"), a Singapore-based biopharmaceutical company focused on harnessing its proprietary technologies to dev...
Benzinga· 4 mins ago
The acquisition includes (i) a cord blood banking licence issued by Malaysia's Ministry of Health, (ii) cryopreservation equipment with more than 12,000 cord blood units, and (iii) two freehold real estate properties totalling 189 square metres in which the operation is situated.This acqui...
$Virpax Pharmaceuticals (VRPX.US)$
$Greenwave Technology Solutions (GWAV.US)$ $Anew Medical (WENA.US)$ $CytoMed Therapeutics (GDTC.US)$
$CytoMed Therapeutics (GDTC.US)$
$MKDWELL Tech (MKDW.US)$ +29%
does anyone know when overnight trading is happening again on Moomoo?
@Moomoo Down Under
progressive I like that 💪
check this out on X x.com
maybe $Greenwave Technology Solutions (GWAV.US)$ can learn how to be more progressive business like CytoMed ha ha ha
CytoMed Therapeutics Limited (NASDAQ: GDTC), a Singapore-based biopharmaceutical company, has recently made a acquisition aimed at bolstering its position in the allogeneic, off-the-shelf donor-derived gamma delta (γδ) T cells technology sector. Through its wholly-owned subsidiary, IPSC Depository Sdn Bhd, CytoMed has acquired the licence and certain assets of C...
No comment yet